Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001185185-25-001757
Filing Date
2025-11-14
Accepted
2025-11-14 17:27:11
Documents
17
Effectiveness Date
2025-11-14

Document Format Files

Seq Description Document Type Size
1 FORM S-8 igcs8103125.htm S-8 250548
2 EXHIBIT 5.1 igcsex5-1.htm EX-5.1 8363
3 EXHIBIT 10.2 igcsex10-2.htm EX-10.2 35293
4 EXHIBIT 23.1 igcsex23-1.htm EX-23.1 2470
5 FILING FEE TABLE igcsex-fee.htm   iXBRL EX-FILING FEES 13252
6 GRAPHIC image_001.jpg GRAPHIC 5038
7 GRAPHIC ex23-1_001.jpg GRAPHIC 10105
  Complete submission text file 0001185185-25-001757.txt   452248

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT igcsex-fee_htm.xml XML 5199
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-291564 | Film No.: 251488346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)